Home / Health / Blood Pressure Pill Recalled for Dissolving Issues
Blood Pressure Pill Recalled for Dissolving Issues
23 Sep
Summary
- Chlorthalidone tablets recalled due to failed dissolution specifications.
- FDA classified the recall as Class II, indicating reversible health risks.
- Over 13,000 bottles of the medication were involved in the recent recall.
Inventia Healthcare Limited in India has issued a recall for 13,567 bottles of chlorthalidone tablets, a common high blood pressure medication. The recall is due to "failed dissolution specifications," meaning the active ingredient may not dissolve adequately for the body to absorb it.
The U.S. Food and Drug Administration (FDA) classified this event as a Class II recall as of September 18th. This classification indicates that the medication's use could lead to temporary or medically reversible adverse health consequences, though the probability of serious harm is considered remote.
This recall follows a previous one in June 2026, which affected over 11,000 bottles of the same medication. Chlorthalidone is a diuretic used to manage high blood pressure and swelling associated with heart, kidney, or liver disease.
Patients with recalled chlorthalidone tablets are advised to consult their pharmacist or healthcare provider before making any changes to their medication regimen. The recalled product is Chlorthalidone Tablets, USP (25 mg), in 100-tablet bottles.
